Biovitrum AB (publ)
News and overview for Biovitrum AB (publ)
The creation of a new niche specialty pharmaceutical company focused on rare diseases - with strong cash flow generation and growth potential [Press Release]
MarketWire | 17 days 22 hours 31 minutes ago
STOCKHOLM, SWEDEN -- (Marketwire) -- 11/05/09 --
Invitation to press- and analyst conference [Press Release]
MarketWire | 17 days 21 hours 55 minutes ago
STOCKHOLM, SWEDEN -- (Marketwire) -- 11/05/09 --
Biogen Idec and Biovitrum Announce Decision to Advance Long-Acting Hemophilia B Therapy into a Registrational Trial [Press Release]
Business Wire | 35 days 6 hours 52 minutes ago
Biogen Idec (NASDAQ: BIIB) and Biovitrum AB (STO: BVT) today announced that they plan to advance the companies’ long-acting, fully-recombinant Factor IX Fc fusion protein (rFIXFc) into a registrational clinical trial in hemophilia B patients. The decision to advance the program is based on promising data from a Phase I/IIa open-label, multi-center, safety dose-escalation and pharmacokinetic study of intravenous rFIXFc in severe, previously-treated hemophilia B patients. rFIXFc was well tolera...
3 Results
Sign up for NAMIC dailyLead
Company Overview
| Company: | Biovitrum AB (publ) |
|---|---|
| Industry: | Pharmaceuticals Manufacturers |
| Website: | http://www.biovitrum.com |
Pharmaceutical company Biovitrum gives specialists the treatments they need. Focusing on select diseases treated by specialist physicians, the company makes pharmaceuticals that treat hemophilia and autoimmune diseases like rheumatoid arthritis, scleroderma (hardening of the skin), and others. Its available products include arthritis drug Kineret and cancer side-effect drug Kepivance. The company also has drugs for inflammatory diseases and fat absorption disorders in development in its pipeline. Biovitrum distributes its products to Europe, Australia, and the US through partnerships with pharmaceutical giants like Pfizer and Amgen.
Key Numbers
| Sales in U.S. Dollars (mil.) | 146.9 (2008) |
|---|---|
| One-year % Growth in Sales | -25.1 (2008) |
| Net Income in U.S. Dollars (mil.) | -43.2 (2008) |
| One-year % Growth in Net Income | 0.0 (2008) |
| Number of Employees | 497 (2008) |
| One-year % Growth in Number of Employees | -8.3 (2008) |
| Fiscal Year-End | December |